6/14/2022

Hydroxychloroquine Sulfate Tablets

Products Affected - Description

- Hydroxychloroquine sulfate tablet, Sandoz, 200 mg, 500 count, NDC 00781-5994-05

Reason for the Shortage

- Amneal had hydroxychloroquine 200 mg tablets on shortage due to increased demand.
- Concordia has Plaquenil 200 mg tablets available.
- Dr. Reddy's has hydroxychloroquine tablets available.
- Major did not provide a reason for the shortage.
- Mylan has hydroxychloroquine 200 mg tablets available.
- Prasco had hydroxychloroquine 200 mg tablets on shortage due to increased demand.
- Rising has hydroxychloroquine tablets available and the company is shipping to forecast.
- Sandoz did not provide a reason for the shortage.
- Sun Pharma discontinued hydroxychloroquine tablets.
- Teva has hydroxychloroquine tablets on shortage due to increased demand.
- Zydus has hydroxychloroquine 200 mg tablets on shortage due to increased demand.

Available Products

- Plaquenil tablet, Concordia, 200 mg, 100 count, NDC 24987-0562-10
- Hydroxychloroquine sulfate tablet, Amneal, 200 mg, 100 count, NDC 69238-1544-01
- Hydroxychloroquine sulfate tablet, Dr. Reddy's, 200 mg, 100 count, NDC 43598-0721-01
- Hydroxychloroquine sulfate tablet, Dr. Reddy's, 200 mg, 500 count, NDC 43598-0721-05
- Hydroxychloroquine sulfate tablet, Major, 200 mg, 50 count, NDC 00904-7046-06
- Hydroxychloroquine sulfate tablet, Major, 200 mg, 100 count, NDC 00904-7046-61
- Hydroxychloroquine sulfate tablet, Mylan, 200 mg, 100 count, NDC 00378-0373-01
- Hydroxychloroquine sulfate tablet, Prasco, 200 mg, 100 count, NDC 66993-0057-02
- Hydroxychloroquine sulfate tablet, Prasco, 200 mg, 500 count, NDC 66993-0057-04
- Hydroxychloroquine sulfate tablet, Rising Pharmaceuticals, 200 mg, 100 count, NDC 42385-0927-01
- Hydroxychloroquine sulfate tablet, Rising Pharmaceuticals, 200 mg, 500 count, NDC 16571-0687-50
- Hydroxychloroquine sulfate tablet, Sandoz, 200 mg, 100 count, NDC 00781-5994-01
- Hydroxychloroquine sulfate tablet, Sun Pharma, 200 mg, 100 count, NDC 57664-0761-88 - discontinued
- Hydroxychloroquine sulfate tablet, Teva, 200 mg, 100 count, NDC 00093-2401-01
- Hydroxychloroquine sulfate tablet, Zydus, 200 mg, 100 count, NDC 68382-0096-01
- Hydroxychloroquine sulfate tablet, Zydus, 200 mg, 500 count, NDC 68382-0096-05

Estimated Resupply Dates

- Sandoz has hydroxychloroquine 200 mg tablets in 500 count bottles on back order and the company cannot estimate a release date.
- All other marketed presentations are available.

Implications for Patient Care

- ASHP has provided stewardship recommendations for off-label use of this treatment for COVID-19. https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/Stewardship-of-Off-Label-Treatments.ashx

Updated

Updated June 14, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 19, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.